Adefovir Dipivoxil Induced Hypophosphatemic Osteomalacia:Report of Two Cases

WANG Xia,ZHENG Hui,ZHANG Zhen-lin
DOI: https://doi.org/10.3969/j.issn.1007-9572.2013.05.094
2013-01-01
Chinese General Practice
Abstract:Objective To investigate clinical manifestations,treatment and prognosis of adefovir dipivoxil(ADV)induced hypophosphatemic osteomalacia.Methods Data of 2 chronic hepatitis B patients who developed hypophosphatemic osteomalacia after long-term administration of ADV(10 mg/d) were analyzed and pertinent literatures at home and abroad reviewed.Results The 2 patients administrated a low dose of ADV for 4,6 years,respectively.Both developed generalized bone pain,difficult movement and other symptoms after 3 years of administration.By laboratory examination,serum phosphate level decreased,alkaline phosphatase increased.The clinical symptoms improved after supplement of active vitamin D and calcium,serum phosphate returned to normal.Conclusion ADV has nephrotoxicity,which is positively correlated with doses and medication time.Long-term administration can lead to hypophosphatemic osteomalacia.
What problem does this paper attempt to address?